X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3866) 3866
Publication (254) 254
Newsletter (130) 130
Book Review (34) 34
Book Chapter (4) 4
Conference Proceeding (3) 3
Magazine Article (2) 2
Data Set (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3057) 3057
oncology (2154) 2154
female (1880) 1880
male (1828) 1828
leucovorin (1804) 1804
middle aged (1540) 1540
aged (1435) 1435
antineoplastic combined chemotherapy protocols - therapeutic use (1390) 1390
leucovorin - administration & dosage (1303) 1303
adult (1272) 1272
fluorouracil (1259) 1259
pharmacology & pharmacy (1240) 1240
fluorouracil - administration & dosage (1207) 1207
index medicus (1121) 1121
colorectal neoplasms - drug therapy (1068) 1068
chemotherapy (1058) 1058
5-fluorouracil (884) 884
cancer (837) 837
colorectal cancer (782) 782
antineoplastic combined chemotherapy protocols - adverse effects (757) 757
oxaliplatin (735) 735
treatment outcome (681) 681
animals (657) 657
leucovorin - pharmacology (656) 656
colorectal neoplasms - pathology (629) 629
leucovorin - therapeutic use (527) 527
antineoplastic combined chemotherapy protocols - administration & dosage (515) 515
organoplatinum compounds - administration & dosage (503) 503
irinotecan (486) 486
fluorouracil - therapeutic use (479) 479
fluorouracil - adverse effects (468) 468
camptothecin - analogs & derivatives (464) 464
drug administration schedule (444) 444
folinic acid (406) 406
1st-line treatment (394) 394
carcinoma (391) 391
aged, 80 and over (390) 390
care and treatment (390) 390
research (388) 388
neoplasm metastasis (380) 380
therapy (374) 374
trial (371) 371
leucovorin - adverse effects (370) 370
disease-free survival (363) 363
dose-response relationship, drug (358) 358
survival analysis (355) 355
medicine & public health (351) 351
bevacizumab (350) 350
camptothecin - administration & dosage (346) 346
adenocarcinoma - drug therapy (338) 338
mice (330) 330
metastatic colorectal-cancer (325) 325
pharmacology/toxicology (322) 322
metastasis (317) 317
capecitabine (313) 313
methotrexate - administration & dosage (303) 303
infusions, intravenous (292) 292
colonic neoplasms - drug therapy (291) 291
methotrexate (287) 287
deoxycytidine - analogs & derivatives (286) 286
fluorouracil - pharmacology (286) 286
combination (270) 270
neoplasm staging (267) 267
survival rate (267) 267
time factors (262) 262
survival (261) 261
antimetabolites, antineoplastic - administration & dosage (254) 254
organoplatinum compounds - adverse effects (252) 252
antineoplastic agents - therapeutic use (251) 251
pharmacokinetics (251) 251
methotrexate - pharmacology (238) 238
drug therapy (233) 233
prognosis (229) 229
antineoplastic agents (228) 228
organoplatinum compounds - therapeutic use (228) 228
colorectal neoplasms - mortality (221) 221
neoplasms - drug therapy (220) 220
phase-ii (220) 220
cancer research (218) 218
antimetabolites, antineoplastic - therapeutic use (208) 208
toxicity (208) 208
deoxycytidine - administration & dosage (206) 206
liver neoplasms - secondary (206) 206
pharmacology (204) 204
administration, oral (203) 203
chemotherapy, adjuvant (201) 201
randomized-trial (201) 201
antimitotic agents (200) 200
colorectal-cancer (198) 198
cisplatin (197) 197
high-dose leucovorin (196) 196
fluorouracil - analogs & derivatives (195) 195
liver neoplasms - drug therapy (189) 189
colonic neoplasms - pathology (187) 187
oncology, experimental (187) 187
antineoplastic agents - administration & dosage (185) 185
clinical trials (185) 185
retrospective studies (181) 181
antineoplastic agents - pharmacology (177) 177
colon cancer (174) 174
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3920) 3920
Japanese (28) 28
French (18) 18
German (10) 10
Spanish (9) 9
Russian (5) 5
Chinese (3) 3
Italian (3) 3
Polish (3) 3
Dutch (2) 2
Korean (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Developmental Biology, ISSN 0012-1606, 09/2015, Volume 405, Issue 1, pp. 108 - 122
Folate deficiency has been associated with numerous diseases and birth defects including orofacial defects. However, whether folate has a role in the face... 
Xenopus | DHFR | Orofacial development | Retinoic acid and primary palate | Folate | OXIDATIVE STRESS | FACIAL CLEFTS | NEURAL-TUBE DEFECTS | DEVELOPMENTAL BIOLOGY | HISTONE BIOSYNTHESIS | FOLIC-ACID | DNA MISMATCH REPAIR | RETINOIC ACID | CRANIOFACIAL DEFECTS | DIHYDROFOLATE-REDUCTASE | CELL-CYCLE | Methotrexate - pharmacology | Apoptosis - drug effects | Cartilage - pathology | Cartilage - drug effects | Embryo, Nonmammalian - drug effects | Muscles - pathology | Neural Crest - metabolism | Tretinoin - metabolism | Biomarkers - metabolism | Cell Survival - drug effects | Cartilage - embryology | Oligonucleotides, Antisense - pharmacology | Embryo, Nonmammalian - pathology | Mouth - embryology | Muscles - embryology | Xenopus laevis | Gene Expression Regulation, Developmental - drug effects | Cleft Palate - embryology | Mouth - metabolism | Receptors, Retinoic Acid - antagonists & inhibitors | Receptors, Retinoic Acid - metabolism | Neural Crest - drug effects | Tetrahydrofolate Dehydrogenase - metabolism | Embryo, Nonmammalian - abnormalities | Animals | Signal Transduction - drug effects | Models, Biological | Muscles - drug effects | Morpholinos - pharmacology | Folic Acid - metabolism | Cell Proliferation - drug effects | Cleft Palate - metabolism | Face - embryology | DNA Damage | Cell Cycle - drug effects | DNA Methylation - drug effects | Leucovorin - pharmacology | Physiological aspects | Dihydrofolate reductase | Methylation | Folic acid | orofacial development | retinoic acid and primary palate
Journal Article
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 7/2015, Volume 76, Issue 1, pp. 97 - 103
Hangeshashinto (TJ-14, a Kampo medicine), which reduces the level of prostaglandin E2 and affects the cyclooxygenase activity, alleviates chemotherapy-induced... 
Medicine & Public Health | TJ-14 | Colorectal Cancer | Oncology | Cancer Research | Oral mucositis | Hangeshashinto | Pharmacology/Toxicology | GASTROINTESTINAL MUCOSITIS | HERBAL MEDICINE | PREVENTION | STOMATITIS | PROINFLAMMATORY CYTOKINES | NECK-CANCER | CLINICAL-PRACTICE GUIDELINES | TRIAL | COOLING CRYOTHERAPY | ONCOLOGY | PHARMACOLOGY & PHARMACY | HANGE-SHASHIN-TO | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Young Adult | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Adult | Camptothecin - administration & dosage | Deoxycytidine - adverse effects | Female | Drugs, Chinese Herbal - therapeutic use | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Double-Blind Method | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Stomatitis - chemically induced | Quality of Life | Stomatitis - prevention & control | Aged | Deoxycytidine - analogs & derivatives | Organoplatinum Compounds - adverse effects | Antimitotic agents | COX-2 inhibitors | Stomatitis | Pyrimidines | Chemotherapy | Analysis | Colorectal cancer | Clinical trials | Antineoplastic agents | Cancer | Index Medicus | Original
Journal Article
International Journal of Oncology, ISSN 1019-6439, 08/2005, Volume 27, Issue 2, pp. 553 - 561
The folate analogue BGC9331 is a new thymidylate synthase (TS) inhibitor showing a broad spectrum of cytotoxic activity against several human solid tumors,... 
Rho-kinase ROCK-1 | Combination chemotherapy | Cell proliferation cycle | Caspasc-3 | HUMAN COLON | 1ST-LINE TREATMENT | MULTICENTER RANDOMIZED-TRIAL | LEUCOVORIN | combination chemotherapy | OXALIPLATIN | ANTITUMOR-ACTIVITY | FLUOROURACIL | ZD9331 | 5-FLUOROURACIL | ONCOLOGY | cell proliferation cycle | CELLULAR PHARMACOLOGY | caspase-3 | Apoptosis - drug effects | Guanine - analogs & derivatives | Humans | Topoisomerase I Inhibitors | Organoplatinum Compounds - pharmacology | Breast Neoplasms - metabolism | Dose-Response Relationship, Drug | Caspases - metabolism | Time Factors | Guanine - pharmacology | rho-Associated Kinases | Caspase 3 | Antineoplastic Agents - pharmacology | Colorectal Neoplasms - metabolism | Protein-Serine-Threonine Kinases - metabolism | Camptothecin - analogs & derivatives | DNA Topoisomerases, Type I - metabolism | Enzyme Inhibitors - pharmacology | Intracellular Signaling Peptides and Proteins | Thymidylate Synthase - metabolism | Caspase Inhibitors | Pemetrexed | Drug Synergism | HT29 Cells | Breast Neoplasms - pathology | Cysteine Proteinase Inhibitors - pharmacology | Glutamates - pharmacology | Cell Line, Tumor | Cell Proliferation - drug effects | Fluorouracil - pharmacology | Thymidylate Synthase - antagonists & inhibitors | Cell Cycle - drug effects | Colorectal Neoplasms - pathology | Oligopeptides - pharmacology | Quinazolines - pharmacology | Camptothecin - pharmacology | Folic Acid Antagonists - pharmacology
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 01/2014, Volume 20, Issue 1, pp. 164 - 175
Journal Article
Clinical Colorectal Cancer, ISSN 1533-0028, 2015, Volume 14, Issue 1, pp. 1 - 10
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 7/2015, Volume 76, Issue 1, pp. 75 - 84
Journal Article
Journal of Surgical Oncology, ISSN 0022-4790, 02/2013, Volume 107, Issue 2, pp. 155 - 159
Objective To assess the effect of chemotherapy plus bevacizumab on tumor vessels, as well as the reversibility of this effect, using contrast‐enhanced... 
microvessel density | hepatic resection | anti‐VEGF therapy | anti-VEGF therapy | SURGERY | RESECTION | PATHOLOGICAL RESPONSE | CAPILLARIES | PREOPERATIVE CHEMOTHERAPY | THERAPY | MORBIDITY | ONCOLOGY | IRINOTECAN | COMPLICATIONS | OXALIPLATIN-BASED CHEMOTHERAPY | Humans | Microvessels - pathology | Oxides | Iron | Liver Neoplasms - therapy | Organoplatinum Compounds - pharmacology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Bevacizumab | Hepatectomy | Fluorouracil - therapeutic use | Antibodies, Monoclonal, Humanized - pharmacology | Ultrasonography | Angiogenesis Inhibitors - therapeutic use | Leucovorin - therapeutic use | Neoadjuvant Therapy | Retrospective Studies | Chemotherapy, Adjuvant | Liver Neoplasms - secondary | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Angiogenesis Inhibitors - pharmacology | Microvessels - drug effects | Treatment Outcome | Liver Neoplasms - diagnostic imaging | Ferric Compounds | Contrast Media | Liver Neoplasms - blood supply | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Fluorouracil - pharmacology | Colorectal Neoplasms - pathology | Leucovorin - pharmacology | Organoplatinum Compounds - therapeutic use | Antimitotic agents | Chemotherapy | Oncology, Experimental | Colorectal cancer | Liver tumors | Research | Metastasis | Antineoplastic agents | Cancer
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2015, Volume 33, Issue 7, pp. 682 - 685
Journal Article